Sign inGet started

ROBERTS JOHN A

Insider CIK 1249872 · CGIX Chief Operating Officer, Director · CING Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
CING Cingulate Inc. A Award deriv2025-06-202025-06-2315,000— $015,000SEC↗
CING Cingulate Inc. A Award deriv2024-06-122024-06-1310,000— $010,000SEC↗
CING Cingulate Inc. A Award deriv2024-06-112024-06-1314,750— $014,750SEC↗
CING Cingulate Inc. A Award deriv2024-06-112024-06-135,000— $05,000SEC↗
CING Cingulate Inc. A Award deriv2024-03-042024-03-065,000— $05,000SEC↗
VYNT Vyant Bio, Inc. A Award deriv2022-03-152022-03-17150,000— $0150,000SEC↗
VYNT Vyant Bio, Inc. P Buy2021-11-242021-11-245,000$2.02 $10.1K39,807SEC↗
VYNT Vyant Bio, Inc. P Buy2021-08-232021-08-2510,406$2.41 $25.1K34,807SEC↗
VYNT Vyant Bio, Inc. P Buy2021-05-262021-05-277,041$3.55 $25.0K312,117SEC↗
VYNT Vyant Bio, Inc. P Buy2021-05-242021-05-277,440$3.38 $25.1K305,076SEC↗
VYNT Vyant Bio, Inc. A Award deriv2021-03-302021-04-01250,000— $0250,000SEC↗
CGIX CANCER GENETICS, INC P Buy2019-01-312019-02-01185,436$0.23 $42.7K297,636SEC↗
CGIX CANCER GENETICS, INC P Buy2019-01-142019-01-16100,000$0.23 $23.0K112,200SEC↗
CGIX CANCER GENETICS, INC A Award deriv2018-05-102018-05-14350,000— $0350,000SEC↗
CGIX CANCER GENETICS, INC P Buy2017-12-152017-12-1812,200$2.00 $24.4K12,200SEC↗
CGIX CANCER GENETICS, INC A Award deriv2017-02-222017-02-2430,000— $030,000SEC↗
CGIX CANCER GENETICS, INC A Award deriv2016-07-112016-07-13120,000— $0120,000SEC↗